Literature DB >> 29114006

Hyperkalemia across the Continuum of Kidney Function.

Biff F Palmer1, Deborah J Clegg2.   

Abstract

Entities:  

Keywords:  Angiotensins; Diabetes Mellitus, Type 2; Humans; Kidney Failure, Chronic; Male; Renal Insufficiency, Chronic; Renin; Sepsis; acute kidney injury; aldosterone; chronic kidney disease; hemodialysis; hyperkalemia; hypertension; kidney transplantation; peritoneal dialysis; renal dialysis; transplant

Mesh：

Substances：

Year:  2017        PMID： 29114006      PMCID： PMC5753321          DOI： 10.2215/CJN.09340817

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

Review 1.  Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system.

Authors:  Biff F Palmer
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

2.  Potassium homeostasis in renal failure.

Authors:  C van Ypersele de Strihou
Journal:  Kidney Int       Date:  1977-06       Impact factor: 10.612

3.  Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort.

Authors:  Klara Torlén; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Tania Vashistha; Rajnish Mehrotra
Journal:  Clin J Am Soc Nephrol       Date:  2012-05-24       Impact factor: 8.237

Review 4.  Individualizing the dialysate in the hemodialysis patient.

Authors:  B F Palmer
Journal:  Semin Dial       Date:  2001 Jan-Feb       Impact factor: 3.455

5.  An extravenal mechanism for the maintenance of potassium balance in severe chronic renal failure.

Authors:  C P Hayes; M E McLeod; R R Robinson
Journal:  Trans Assoc Am Physicians       Date:  1967

6.  Treatment and prevention of hyperkalemia in end-stage renal disease.

Authors:  M Allon
Journal:  Kidney Int       Date:  1993-06       Impact factor: 10.612

7.  Potassium Sensing by Renal Distal Tubules Requires Kir4.1.

Authors:  Catherina A Cuevas; Xiao-Tong Su; Ming-Xiao Wang; Andrew S Terker; Dao-Hong Lin; James A McCormick; Chao-Ling Yang; David H Ellison; Wen-Hui Wang
Journal:  J Am Soc Nephrol       Date:  2017-01-04       Impact factor: 10.121

Review 8.  Regulation of Potassium Homeostasis.

Authors:  Biff F Palmer
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 8.237

Review 9.  Achieving the Benefits of a High-Potassium, Paleolithic Diet, Without the Toxicity.

Authors:  Biff F Palmer; Deborah J Clegg
Journal:  Mayo Clin Proc       Date:  2016-03-03       Impact factor: 7.616

10.  The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension.

Authors:  Ewout J Hoorn; Stephen B Walsh; James A McCormick; Antje Fürstenberg; Chao-Ling Yang; Tom Roeschel; Alexander Paliege; Alexander J Howie; James Conley; Sebastian Bachmann; Robert J Unwin; David H Ellison
Journal:  Nat Med       Date:  2011-10-02       Impact factor: 53.440
  10 in total
  8 in total

Review 1.  Chronic Kidney Disease and Dietary Measures to Improve Outcomes.

Authors:  Oleh M Akchurin
Journal:  Pediatr Clin North Am       Date:  2019-02       Impact factor: 3.278

2.  Dialysate Potassium and Mortality in a Prospective Hemodialysis Cohort.

Authors:  Antoney Ferrey; Amy S You; Csaba P Kovesdy; Tracy Nakata; Mary Veliz; Danh V Nguyen; Kamyar Kalantar-Zadeh; Connie M Rhee
Journal:  Am J Nephrol       Date:  2018-06-07       Impact factor: 3.754

3.  Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial.

Authors:  Rajiv Agarwal; Amer Joseph; Stefan D Anker; Gerasimos Filippatos; Peter Rossing; Luis M Ruilope; Bertram Pitt; Peter Kolkhof; Charlie Scott; Robert Lawatscheck; Daniel J Wilson; George L Bakris
Journal:  J Am Soc Nephrol       Date:  2021-11-03       Impact factor: 10.121

4.  A quantitative systems pharmacology model of plasma potassium regulation by the kidney and aldosterone.

Authors:  Erfan Maddah; K Melissa Hallow
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-07-01       Impact factor: 2.410

5.  Hypokalemia and hyperkalemia in patients on peritoneal dialysis: incidence and associated factors.

Authors:  Fernanda A Goncalves; Jessica Santos de Jesus; Lilian Cordeiro; Maria Clara T Piraciaba; Luiza K R P de Araujo; Carolina Steller Wagner Martins; Maria Aparecida Dalboni; Benedito J Pereira; Bruno C Silva; Rosa Maria A Moysés; Hugo Abensur; Rosilene M Elias
Journal:  Int Urol Nephrol       Date:  2020-02-03       Impact factor: 2.370

Review 6.  Hyperkalemia: pathophysiology, risk factors and consequences.

Authors:  Robert W Hunter; Matthew A Bailey
Journal:  Nephrol Dial Transplant       Date:  2019-12-01       Impact factor: 7.186

7.  The effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in critically ill patients with acute kidney injury: An observational study using the MIMIC database.

Authors:  Xu Zhu; Jing Xue; Zheng Liu; Wenjie Dai; Jingsha Xiang; Hui Xu; Qiaoling Zhou; Quan Zhou; Xinran Wei; Wenhang Chen
Journal:  Front Pharmacol       Date:  2022-08-29       Impact factor: 5.988

8.  Association between hyperkalemia, RAASi non-adherence and outcomes in chronic kidney disease.

Authors:  Antonio Santoro; Valentina Perrone; Elisa Giacomini; Diego Sangiorgi; Davide Alessandrini; Luca Degli Esposti
Journal:  J Nephrol       Date:  2021-06-11       Impact factor: 3.902
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.